Granite BioListed
granitebio.combiotech_life_sciences
Granite Bio is a biotechnology company developing first-in-class antibodies targeting the root causes of inflammatory, autoimmune, and fibrotic diseases.
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
Granite Bio is a biotechnology company developing first-in-class antibodies targeting the root causes of inflammatory, autoimmune, and fibrotic diseases.
Crinetics is a global pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for endocrine diseases and endocrine-related tumors.
Details are not available yet. The company remains listed.
Monte Rosa Therapeutics is focused on developing molecular glue degraders (MGDs) that target undruggable proteins for therapeutic purposes, particularly in immunology and inflamma…
Hotspur Technologies offers IT solutions and services including web development, app development, and technical support. They provide cutting-edge technology services tailored to…
Bright Peak Therapeutics is focused on developing advanced cytokine-based immunotherapies that enhance anti-tumor efficacy while reducing systemic toxicity.
Black Diamond Therapeutics is a clinical-stage oncology company focused on the development of MasterKey therapies that address families of oncogenic mutations in clinically valida…
Details are not available yet. The company remains listed.
Dualitas Therapeutics is a biotechnology company pioneering next-generation bispecific antibody (BsAb) therapies for immunology and inflammation (I&I). The company utilizes its pr…
Helicore Bio is developing long-acting therapies in obesity and cardiometabolic disease using our proprietary antibody-peptide conjugate platform. We have developed proprietary li…
SixPeaks Bio AG is developing innovative therapies for healthy weight loss and metabolic fitness, focusing on preserving skeletal muscle mass while utilizing GLP-1 receptor agonis…
AllRock Bio is a clinical-stage biotechnology company focused on advancing impactful therapies for cardiopulmonary diseases, particularly pulmonary arterial hypertension and inter…
Gate Bioscience is creating a new class of small molecule therapeutics called Molecular Gates, which selectively eliminate harmful extracellular proteins linked to diseases.
Details are not available yet. The company remains listed.